首页> 美国卫生研究院文献>The Journal of Pharmacology and Experimental Therapeutics >The Prototypical Ranitidine Analog JWS-USC-75-IX Improves Information Processing and Cognitive Function in Animal Models
【2h】

The Prototypical Ranitidine Analog JWS-USC-75-IX Improves Information Processing and Cognitive Function in Animal Models

机译:雷尼替丁类似物的原型JWS-USC-75-IX改善了动物模型中的信息处理和认知功能

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This study was designed to evaluate further a prototypical ranitidine analog, JWS-USC-75-IX, [(3-[[[2-[[(5-dimethylaminomethyl)-2-furanyl]methyl]thio]ethyl]amino]-4-nitropyridazine, JWS], for neuropharmacologic properties that would theoretically be useful for treating cognitive and noncognitive behavioral symptoms of neuropsychiatric disorders. JWS was previously found to inhibit acetylcholinesterase (AChE) activity, serve as a potent ligand at muscarinic M2 acetylcholine receptors, and elicit positive effects on spatial learning, passive avoidance, and working memory in rodents. In the current study, JWS was evaluated for binding activity at more than 60 neurotransmitter receptors, transporters, and ion channels, as well as for inhibitory activity at AChE and butyrylcholinesterase (BChE). The results indicate that JWS inhibits AChE and BChE at low (micromolar) concentrations and that it is a functional antagonist at M2 receptors (KB = 320 nM). JWS was subsequently evaluated orally across additional behavioral assays in rodents (dose range, 0.03–10.0 mg/kg) as well as nonhuman primates (dose range, 0.05–2.0 mg/kg). In rats, JWS improved prepulse inhibition (PPI) of the acoustic startle response in nonimpaired rats and attenuated PPI deficits in three pharmacologic impairment models. JWS also attenuated scopolamine and (−)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine maleate (MK-801)-related impairments in a spontaneous novel object recognition task and a five-choice serial reaction time task, respectively. In monkeys, JWS elicited dose-dependent improvements of a delayed match-to-sample task as well as an attention-related version of the task where randomly presented (task-relevant) distractors were presented. Thus, JWS (potentially via effects at several drug targets) improves information processing, attention, and memory in animal models and could potentially treat the cognitive and behavioral symptoms of some neuropsychiatric illnesses.
机译:这项研究旨在进一步评估原型雷尼替丁类似物JWS-USC-75-IX,[(3-[[[2-[[(5-二甲基氨基甲基)-2-呋喃基]甲基]硫代]乙基]氨基]- 4-硝基哒嗪[JWS]具有神经药理学特性,理论上可用于治疗神经精神疾病的认知和非认知行为症状,以前发现JWS具有抑制乙酰胆碱酯酶(AChE)活性的作用,可作为毒蕈碱M2乙酰胆碱受体的有效配体,以及对啮齿类动物的空间学习,被动回避和工作记忆产生积极影响;在当前研究中,对JWS评估了60多种神经递质受体,转运蛋白和离子通道的结合活性,以及​​对AChE和丁酰胆碱酯酶的抑制活性(BChE)。结果表明,JWS在低(微摩尔)浓度下会抑制AChE和BChE,并且是M2受体(KB = 320 nM)的功能性拮抗剂。在啮齿动物(剂量范围为0.03-10.0 mg / kg)和非人类灵长类动物(剂量范围为0.05-2.0 mg / kg)中进行其他行为分析。在大鼠中,JWS在三种药理损伤模型中改善了非受损大鼠的惊吓反应的脉冲前抑制(PPI),并减轻了PPI缺陷。 JWS还在自发的新型物体识别任务中减弱了东pol碱和(-)-5-甲基-10,11-二氢-5H-二苯并[a,d]环庚-5,10-亚胺马来酸酯(MK-801)相关的损伤。和五选择序列反应时间任务。在猴子中,JWS引发了延迟的匹配样品任务以及与注意力有关的任务的剂量依赖性改善,其中随机呈现了与任务有关的干扰物。因此,JWS(可能通过对几种药物靶点的作用)改善了动物模型中的信息处理,注意力和记忆力,并有可能治疗某些神经精神疾病的认知和行为症状。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号